Shimla Online

Pulmonary Arterial Hypertension Epidemiology Forecast to 2030 by DelveInsight

 Breaking News
  • No posts were found

Pulmonary Arterial Hypertension Epidemiology Forecast to 2030 by DelveInsight

January 21
17:40 2021
Pulmonary Arterial Hypertension Epidemiology Forecast to 2030 by DelveInsight

 

DelveInsight has launched a new report on Pulmonary Arterial Hypertension Epidemiology

 

Pulmonary Arterial Hypertension is a rare, chronic, and progressive form of Pulmonary Hypertension which is characterized by the elevated pulmonary arterial pressure (PAP) and pulmonary vascular resistance (PVR) in blood vessels carrying the blood from the right side of the heart through lungs. It occurs due to the tightening and stiffening of the small pulmonary arteries leading to the right ventricular dysfunction and vessel obstruction.

 

DelveInsight’s ‘Pulmonary Arterial Hypertension Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Pulmonary Arterial Hypertension in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.

 

Pulmonary Arterial Hypertension Epidemiology

The disease is found to be more common among women as compared to men. It is also observed that the patients with Systemic Sclerosis, Sickle Cell Disease, and Human Immunodeficiency Virus infection (HIV infection) are at a higher risk of developing Pulmonary Arterial Hypertension (PAH).

 

Key facts of the Pulmonary Arterial Hypertension Epidemiology

  • As per a study conducted by Noam Y. Kirson et al., the prevalence of Pulmonary Arterial Hypertension was observed to be 109 per million individuals (PMI) among the population of less than 65 years old. The prevalence of Pulmonary Arterial Hypertension was found to be 451 per million individuals (PMI) among age-groups older than 65 years.
  • The “Spanish Registry of Pulmonary Arterial Hypertension (REHAP)”, which included all patients from 1998 to 2008, has calculated the incidence and prevalence rate of Pulmonary Arterial Hypertension as the ratio of newly diagnosed patients from 2007 to 2008. Approximately 16.2% of patients are newly diagnosed with Pulmonary Arterial Hypertension. The overall prevalence of Pulmonary Hypertension was found to be 19.2 cases per Million Adult Inhabitants (MAI) among the Spanish population.
  • According to DelveInsight’s estimates, in 2017 the total prevalent cases of Pulmonary Arterial Hypertension were 70,557 in the seven major markets.

 

Pulmonary Arterial Hypertension Epidemiology Segmentation

  • Prevalent Population of PAH in 7MM [2017–2030]
  • Subtype-Specific Prevalent Population of PAH in 7MM [2017–2030]
  • Gender-Specific Prevalent Population of PAH in 7MM [2017–2030]

 

Pulmonary Arterial Hypertension Epidemiology Report Scope

  • The report covers detailed overview of Pulmonary Arterial Hypertension explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns

• The report provides the insight about the historical and forecasted patient pool of Pulmonary Arterial Hypertension in 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) and Japan.

• The Report assesses the disease risk and burden and highlights the unmet needs of the disease

• The Report helps to recognize the growth opportunities in the 7MM with respect to the patient population

• The report provides the segmentation of the disease total prevalent population of PAH, subtype-specific population of PAH and gender-specific PAH diagnosed pool in 7MM

 

Request for free sample copy- https://www.delveinsight.com/sample-request/pulmonary-arterial-hypertension-epidemiology-forecast

 

Table of content

1. Key Insights

2. Executive Summary of Pulmonary Arterial Hypertension

3. SWOT Analysis for Pulmonary Arterial Hypertension

4. Pulmonary Arterial Hypertension (PAH) Epidemiology Overview at a Glance

5. Disease Background and Overview: Pulmonary Arterial Hypertension (PAH)

6. Epidemiology and Patient Population

7. Country Wise-Epidemiology of Pulmonary Arterial Hypertension (PAH)

8. Treatment Algorithm

9. Unmet Needs

10. Case Studies

11. Organizations related with PAH

12. Appendix

13. DelveInsight Capabilities

14. Disclaimer

15. About DelveInsight

 

Request for free sample copy- https://www.delveinsight.com/sample-request/pulmonary-arterial-hypertension-epidemiology-forecast

 

Related Reports

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Related Articles